PNC Financial Services Group’s Albany Molecular Research Inc AMRI Stock Holding History

PNC Financial Services Group’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-171	Closed	-$4K	–	4338
2017 Q2	$4K	Buy	171 +99	+138%	+$1.8K	﹤0.01%	3895
2017 Q1	$1K	Buy	72 +3	+4%	+$49	﹤0.01%	4088
2016 Q4	$1K	Buy	+69	New	+$1.17K	﹤0.01%	3976
2016 Q3	–	Sell	-84	Closed	-$1K	–	4517
2016 Q2	$1K	Sell	84 -92	-52%	-$1.34K	﹤0.01%	4454
2016 Q1	$3K	Buy	176 +6	+4%	+$94	﹤0.01%	4116
2015 Q4	$3K	Hold	170	–	–	﹤0.01%	4092
2015 Q3	$3K	Buy	170 +6	+4%	+$122	﹤0.01%	4214
2015 Q2	$3K	Buy	164 +75	+84%	+$1.45K	﹤0.01%	4316
2015 Q1	$2K	Hold	89	–	–	﹤0.01%	4375
2014 Q4	$1K	Buy	+89	New	+$1.63K	﹤0.01%	4080

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

PNC Financial Services Group's AMRI Position: Q3 2017 in Review

PNC Financial Services Group sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 171 shares — an estimated $4K sold.

PNC Financial Services Group first reported a position in AMRI in Q4 2014 and held it in 10 quarters. The position peaked at $4K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

PNC Financial Services Group reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
PNC Financial Services Group sold 171 Albany Molecular Research Inc shares in Q3 2017, an estimated $4K.
PNC Financial Services Group first reported a position in Albany Molecular Research Inc in Q4 2014 and held it in 10 quarters.
PNC Financial Services Group's Albany Molecular Research Inc position peaked at $4K in Q2 2017.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on PNC Financial Services Group's 13F filing for Q3 2017, filed 13 Nov 2017.